Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L D True

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Gastroenterology|September 1, 1990
Clinical and pathological characteristics of hepatotoxicity associated with occupational exposure to dimethylformamideC A Redlich, A B West, L Fleming, et al.
Journal of the American Academy of Dermatology|June 1, 1991
Juvenile xanthogranulomas with inconspicuous or absent foam cells and giant cellsP E Shapiro, D N Silvers, R K Treiber, et al.
Radiology|September 1, 1994
Testicular microlithiasis: imaging appearances and pathologic correlationM L Backus, L A Mack, W D Middleton, et al.
BJU International|June 20, 2001
Consensus development of a histopathological classification system for chronic prostatic inflammationJ C Nickel, L D True, J N Krieger, et al.
Cancer Research|September 15, 1999
Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2B Lin, C Ferguson, J T White, et al.
Urology|April 18, 2001
Osteoprotegerin and rank ligand expression in prostate cancerJ M Brown, E Corey, Z D Lee, et al.
Clinical & Experimental Metastasis|April 23, 2003
Bone histology at autopsy and matched bone scintigraphy findings in patients with hormone refractory prostate cancer: the effect of bisphosphonate therapy on bone scintigraphy resultsM P Roudier, H Vesselle, L D True, et al.
Cancer Research|January 27, 1998
Hevin, an antiadhesive extracellular matrix protein, is down-regulated in metastatic prostate adenocarcinomaP S Nelson, S R Plymate, K Wang, et al.
Cancer Research|March 14, 2001
Prostate short-chain dehydrogenase reductase 1 (PSDR1): a new member of the short-chain steroid dehydrogenase/reductase family highly expressed in normal and neoplastic prostate epitheliumB Lin, J T White, C Ferguson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1997
Identification of rat prostatic steroid-binding protein as a target antigen of experimental autoimmune prostatitis: implications for prostate cancer therapyK J Liu, G S Chatta, D R Twardzik, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Gastroenterology|September 1, 1990
Clinical and pathological characteristics of hepatotoxicity associated with occupational exposure to dimethylformamideC A Redlich, A B West, L Fleming, et al.
Journal of the American Academy of Dermatology|June 1, 1991
Juvenile xanthogranulomas with inconspicuous or absent foam cells and giant cellsP E Shapiro, D N Silvers, R K Treiber, et al.
Radiology|September 1, 1994
Testicular microlithiasis: imaging appearances and pathologic correlationM L Backus, L A Mack, W D Middleton, et al.
BJU International|June 20, 2001
Consensus development of a histopathological classification system for chronic prostatic inflammationJ C Nickel, L D True, J N Krieger, et al.
Cancer Research|September 15, 1999
Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2B Lin, C Ferguson, J T White, et al.
Urology|April 18, 2001
Osteoprotegerin and rank ligand expression in prostate cancerJ M Brown, E Corey, Z D Lee, et al.
Clinical & Experimental Metastasis|April 23, 2003
Bone histology at autopsy and matched bone scintigraphy findings in patients with hormone refractory prostate cancer: the effect of bisphosphonate therapy on bone scintigraphy resultsM P Roudier, H Vesselle, L D True, et al.
Cancer Research|January 27, 1998
Hevin, an antiadhesive extracellular matrix protein, is down-regulated in metastatic prostate adenocarcinomaP S Nelson, S R Plymate, K Wang, et al.
Cancer Research|March 14, 2001
Prostate short-chain dehydrogenase reductase 1 (PSDR1): a new member of the short-chain steroid dehydrogenase/reductase family highly expressed in normal and neoplastic prostate epitheliumB Lin, J T White, C Ferguson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1997
Identification of rat prostatic steroid-binding protein as a target antigen of experimental autoimmune prostatitis: implications for prostate cancer therapyK J Liu, G S Chatta, D R Twardzik, et al.
Pageof 7